Research location
Blue Ridge
Georgia, United States
Advertisement
Research activity in Blue Ridge
Georgia, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 73 trials and 73 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Blue Ridge
73 linked trials · page 2 of 2A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid ArthritisNCT00531817 · 2007-10-01 · 1 site observation
COMPLETED
Naturlose (D-Tagatose) Efficacy Evaluation TrialNCT00955747 · 2007-04-01 · 1 site observation
COMPLETED
Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes MellitusNCT00432276 · 2007-01-01 · 1 site observation
COMPLETED
A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPDNCT00419744 · 2007-01-01 · 1 site observation
COMPLETED
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 DiabetesNCT00411892 · 2006-11-29 · 1 site observation
TERMINATED
Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of HypertensionNCT00281593 · 2006-04-01 · 1 site observation
COMPLETED
A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).NCT00380796 · 2006-04-01 · 1 site observation
COMPLETED
Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)NCT00297115 · 2006-03-01 · 1 site observation
COMPLETED
To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1cNCT00294723 · 2006-02-01 · 1 site observation
TERMINATED
A Trial of BMS-512148 in Patients With Type 2 Diabetes MellitusNCT00263276 · 2005-12-01 · 1 site observation
COMPLETED
Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's TypeNCT00160147 · 2005-12-01 · 1 site observation
TERMINATED
Study of Muraglitazar Versus Pioglitazone in Type 2 DiabetesNCT00106808 · 2005-08-01 · 1 site observation
COMPLETED
A Study of DPP-IV Inhibitor in Patients With Type 2 DiabetesNCT00111670 · 2005-06-01 · 1 site observation
COMPLETED
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF TherapyNCT00124982 · 2005-04-01 · 1 site observation
COMPLETED
A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPDNCT00206167 · 2005-04-01 · 1 site observation
COMPLETED
A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD PatientsNCT00206154 · 2005-04-01 · 1 site observation
COMPLETED
Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin AloneNCT00095030 · 2004-02-01 · 1 site observation
COMPLETED
Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On InsulinNCT00329225 · 2002-09-01 · 1 site observation
COMPLETED
GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 DiabetesNCT00280865 · 2002-04-01 · 1 site observation
COMPLETED
Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT00268216 · 2000-09-01 · 1 site observation
COMPLETED
Rosiglitazone on Microalbuminuria in Type 2 DiabeticsNCT00500955 · 2000-04-01 · 1 site observation
COMPLETED
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/GlibenclamideNCT00279045 · 2000-01-03 · 1 site observation
COMPLETED
Study in Patients With COPDNCT00215449 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.